Profound Medical Sees FY2026 Sales $25.000M

Benzinga Newsdesk www.benzinga.com Neutral 85.7%

Neg 0% Neu 85.7% Pos 0%

Profound Medical (CSE2: PRN) sees FY2026 sales of $25.000 million.

Comments

No comments yet. Be the first!